Pacific Biosciences Of California | PACB - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.23B 113M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Danaher USD 6.81B 483M 2025-12
General Electric Aerospace USD 38.98B 1.78B 2025-12
Illumina USD 1.59B 377M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
Pacific Biosciences Of California USD 72.83M 9.62M 2025-12
Quidel USD 966.1M 198.2M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Roche Holding CHF 28B 421M 2025-12
Standard Biotools USD 108.31M 343K 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Waters USD 1.24B 11.8M 2025-12